Uric Acid Study in Healthy Male Volunteers

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study is being conducted to examine the effect of AZD6140 on the levels of certain chemicals in subjects' blood and urine.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: AstraZeneca
• Treatments: Ticagrelor; Uric Acid

Criteria

Inclusion Criteria:

• Normal physical examination, vital signs, electrocardiogram (ECG) and laboratory values (unless the investigator considers an abnormality not to be clinically significant)

• Normal laboratory tests at screening

• Non-smoker (no cigarette/tobacco use for at least 6 months)

Exclusion Criteria:

• Personal or family history of gout, gouty arthritis, or renal stones